Lower cardiovascular risk with SGLT-2 inhibitors vs other glucose-lowering drugs: real world data from Asia Pacific, North America, Europe and Middle East: the CVD-REAL study Conference Paper uri icon

authors

  • Kosiborodl, M
  • Lam, CSP
  • Kohsaka, S
  • Kim, D
  • Karasik, A
  • Goh, S-Y
  • Shaw, Jonathan
  • Tangri, N
  • Norhammar, A
  • Franch-Nadal, J
  • Thuresson, M
  • Surmont, F
  • Hammar, N
  • Fenici, P

publication date

  • 2018